Aspen Leadership Group is proud to partner with Scripps Research
in the search for an Associate Vice President, Philanthropy.
Reporting to the Vice President, Philanthropy, the Associate Vice
President, Philanthropy will manage a growing and comprehensive
fundraising program that includes oversight of annual giving, major
giving, planned and estate giving, and corporate and foundation
giving. Working closely with the President and Vice President,
Philanthropy, the Associate Vice President will expand broad
reaching fundraising efforts, working with donors and prospects
with the capacity to give at the level of $5 million and above. The
Associate Vice President will be a key fundraising strategist who
acts as an influential relationship connector among Office of
Philanthropy leaders, senior leadership, faculty leaders, and
high-capacity donors and prospects.
Scripps Research ranks as the most influential scientific
organization in the world, unparalleled in propelling innovation in
science and medicine. Its unique structure merges foundational
studies in biology, chemistry, and computer science with
translational science to produce the next generation of drugs and
advances in digital and precision medicine. Scientists in the
Institute’s five academic research departments work hand-in-hand
with researchers of the Scripps Research Translational Institute
and Calibr. Together, Scripps Research cultivates the next
generation of scientific leaders and expands the frontiers of
knowledge to drive innovation that improves lives around the
planet.
Scripps Research enjoys a rich history of academic and scientific
achievement. Its world-class faculty and visionary leadership have
partnered to create a top-ranked nonprofit biomedical research
institute that translates discoveries into new medicines while
training the next generation of scientists.
The work of researchers and scientists at Scripps Research has led
to many breakthroughs in medical treatments. In 1990, work by
Theodore Zimmerman, MD, and Carol Fulcher, PhD, resulted in the
approval of Monoclate by the FDA. The blood coagulant is used to
prevent excessive bleeding in patients with hemophilia. Three years
later, Ernest Beutler, MD led the team that tested the new
anti-cancer drug, 2CdA (Leustatin) developed at Scripps Research by
Dennis Carson, MD. It was characterized as one of the most
promising chemotherapeutic agents developed and subsequently
produced a large number of complete remissions in patients with
hairy cell leukemia, as well as other leukemias and
lymphomas.
By searching among billions of antibody variants taken from human
blood samples, a technique called “combinational antibody
libraries” enabled scientists to identify human antibodies that
bind to specific targets involved in disease. This work, stemming
from research in the lab of Richard Lerner, MD, led to development
of the drug, Humira, which was approved by the FDA to treat
rheumatoid arthritis in 2002. Humira was later approved for the
treatment of psoriatic arthritis, ankylosing spondylitis, Crohn’s
disease, plaque psoriasis, juvenile idiopathic arthritis, and
moderate-to-severe ulcerative colitis. Research has led to many
other breakthroughs by Scripps, including treatment for lupus;
respiratory distress syndrome; gastric cancer and non-small cell
lung cancer; high-risk cases of neuroblastoma; relapsing forms of
multiple sclerosis; and many more.
Scripps Research continues to expand its fields of research. In
2022, Scripps Research received a $67 million award from the
National Institute of Allergy and Infectious Diseases, part of the
National Institutes of Health, to establish and lead a Center for
Antiviral Medicines and Pandemic Preparedness (CAMPP). A U.S.
government response to the COVID-19 pandemic, the center focuses on
near-term development of drugs against viruses with high pandemic
potential.
Some of the most brilliant minds in the world join forces at
Scripps Research. Chemists at Scripps Research have won six Wolf
Prizes. Scientists have also won six Nobel Awards. One scientist
has received the Breakthrough Prize in Life Sciences and the
faculty currently includes two MacArthur Fellows. Scripps faculty
also hold 31 memberships in the prestigious National Academies of
Sciences, Medicine, and Engineering. Scientific teams collaborate
across disciplines to improve human health. There are more than 175
faculty members working to advance scientific knowledge and the
drug discovery division, Calibr, has more than 50 potential
medicines in the pipeline. There are 15 FDA-approved drugs and
vaccines that have risen from discoveries at Scripps Research.
Scripps Research also educates and trains the scientific leaders of
tomorrow. The Skaggs Graduate School of Chemical and Biological
Sciences at Scripps Research in consistently ranked among the
ten-best graduate programs of its kind in the nation by U.S.
News & World Report.
Every day, Scripps Research makes an impact nationally
with more than 50 active spin-off companies, 1,100 U.S. patents,
and $295 million in annual federal and state grant expenditures.
That impact spans globally as well with 13 faculty earning spots on
the 2022 Highly Cited Researchers list (representing the top one
percent in the world). Scientists at Scripps Research address
diseases affecting 85% of the world’s population. Scripps Research
is science changing life.
Scripps Research will consider candidates with a broad range of
backgrounds. A bachelor’s degree or an equivalent combination of
education and experience and at least five years of experience
securing principal gifts and managing a fundraising team,
preferably in biomedical research, healthcare, or higher education,
is preferred. All applications must be accompanied by a cover
letter and résumé. Cover letters should be responsive to the
mission of Scripps Research as well as the responsibilities and
qualifications presented in the prospectus.
The salary range for this position is $200,000 to $300,000
annually.
To apply for this position, visit:
https://opportunities.aspenleadershipgroup.com/opportunities/1328.
Credit:Source link
